Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Core Insights - Lifecore Biomedical, Inc. will participate as a Gold Sponsor at the 24th Annual Contract Pharma Contracting and Outsourcing Conference on September 18-19, 2025, in New Brunswick, NJ, highlighting its commitment to the pharmaceutical outsourcing and contract manufacturing sector [1][2]. Company Overview - Lifecore is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [4]. - The company has over 40 years of experience in partnering with global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories [4]. Growth Strategy - Lifecore's growth strategy focuses on three main areas: expanding existing customer relationships, advancing its late-stage development portfolio towards commercialization, and attracting new, high-value business [2][3]. - The participation in the Contract Pharma conference is part of the company's efforts to elevate awareness of its unique injectables development and manufacturing expertise [3]. Event Participation - At the conference, Lifecore will host meetings with existing and prospective customers and partners, aiming to strengthen its market presence and foster new business opportunities [3].